This progressive lung disease transforms healthy tissue into stiff, scarred areas making breathing difficult. Learn the ...

Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, ...

Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting ...

Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting ...

Toxic dust on Mars would make a future mission to the red planet extremely hazardous for astronauts and require significant ...

Pulmonary hypertension is a common consequence of interstitial lung disease (PH-ILD), with the highest rate seen among ...

Tribune Therapeutics has secured €37m ($39.9m) in seed and Series A funding to propel its therapy portfolio aimed at the ...

Shares of Pliant Therapeutics PLRX have plunged 88.5% in the past three months following recent setbacks in the clinical ...

Valeria Guzman, 24, said it "was heart-wrenching" to see her dad connected to so much machinery and in so much pain, but she ...

Haisco Pharmaceutical Group Co. Ltd. has described lysophosphatidic acid receptor 1 (LPAR1; EDG2) antagonists reported to be useful for the treatment of idiopathic pulmonary fibrosis, systemic ...